Seuraa
Suzanne E. Schindler
Suzanne E. Schindler
Washington University School of Medicine
Vahvistettu sähköpostiosoite verkkotunnuksessa neuro.wustl.edu
Nimike
Viittaukset
Viittaukset
Vuosi
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
SE Schindler, JG Bollinger, V Ovod, KG Mawuenyega, Y Li, BA Gordon, ...
Neurology 93 (17), e1647-e1659, 2019
7952019
Cholesterol-dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains
S Wahrle, P Das, AC Nyborg, C McLendon, M Shoji, T Kawarabayashi, ...
Neurobiology of disease 9 (1), 11-23, 2002
5532002
ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE
SE Wahrle, H Jiang, M Parsadanian, J Legleiter, X Han, JD Fryer, ...
Journal of Biological Chemistry 279 (39), 40987-40993, 2004
5412004
Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease
SE Wahrle, H Jiang, M Parsadanian, J Kim, A Li, A Knoten, S Jain, ...
The Journal of clinical investigation 118 (2), 671-682, 2008
4532008
Deletion of Abca1 increases Aβ deposition in the PDAPP transgenic mouse model of Alzheimer disease
SE Wahrle, H Jiang, M Parsadanian, RE Hartman, KR Bales, SM Paul, ...
Journal of Biological Chemistry 280 (52), 43236-43242, 2005
3962005
Assessment of racial disparities in biomarkers for Alzheimer disease
JC Morris, SE Schindler, LM McCue, KL Moulder, TLS Benzinger, ...
JAMA neurology 76 (3), 264-273, 2019
3092019
Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging
SE Schindler, JD Gray, BA Gordon, C Xiong, R Batrla-Utermann, M Quan, ...
Alzheimer's & Dementia 14 (11), 1460-1469, 2018
2492018
Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease
LM Shaw, J Arias, K Blennow, D Galasko, JL Molinuevo, S Salloway, ...
Alzheimer's & Dementia 14 (11), 1505-1521, 2018
2282018
Validation of plasma amyloid-β 42/40 for detecting Alzheimer disease amyloid plaques
Y Li, SE Schindler, JG Bollinger, V Ovod, KG Mawuenyega, MW Weiner, ...
Neurology 98 (7), e688-e699, 2022
1662022
Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease
AL Ferreiro, JH Choi, J Ryou, EP Newcomer, R Thompson, RM Bollinger, ...
Science translational medicine 15 (700), eabo2984, 2023
1562023
Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-β
M Morikawa, JD Fryer, PM Sullivan, EA Christopher, SE Wahrle, ...
Neurobiology of disease 19 (1-2), 66-76, 2005
1492005
Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests
NR Barthélemy, G Salvadó, SE Schindler, Y He, S Janelidze, LE Collij, ...
Nature medicine 30 (4), 1085-1095, 2024
1482024
Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Aβ42 accumulation in amyloid model mice
CV Zerbinatti, SE Wahrle, H Kim, JA Cam, K Bales, SM Paul, ...
Journal of Biological Chemistry 281 (47), 36180-36186, 2006
1472006
Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape
H Hampel, Y Hu, J Cummings, S Mattke, T Iwatsubo, A Nakamura, ...
Neuron 111 (18), 2781-2799, 2023
1122023
Effect of race on prediction of brain amyloidosis by plasma Aβ42/Aβ40, phosphorylated tau, and neurofilament light
SE Schindler, TK Karikari, NJ Ashton, RL Henson, KE Yarasheski, T West, ...
Neurology 99 (3), e245-e257, 2022
1122022
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
K Horie, G Salvadó, NR Barthélemy, S Janelidze, Y Li, Y He, B Saef, ...
Nature medicine 29 (8), 1954-1963, 2023
1072023
Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1polymorphisms
SE Wahrle, AR Shah, AM Fagan, S Smemo, JSK Kauwe, A Grupe, ...
Molecular neurodegeneration 2, 1-9, 2007
1032007
Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy
K Yanamandra, TK Patel, H Jiang, S Schindler, JD Ulrich, AL Boxer, ...
Science translational medicine 9 (386), eaal2029, 2017
992017
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
SE Schindler, Y Li, KW Todd, EM Herries, RL Henson, JD Gray, G Wang, ...
Alzheimer's & Dementia 15 (5), 655-665, 2019
982019
ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes
A Soldan, C Pettigrew, AM Fagan, SE Schindler, A Moghekar, C Fowler, ...
Neurology 92 (14), e1567-e1579, 2019
962019
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20